Skip to main content

Closed

XTLB: XTL Biopharmaceuticals Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.01×avg

Market Cap

6.67MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ Capital Market·USD·Closed

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ·USD·Closed

$2.82

−1.05%

$2.82

−$0.03 (1.05%)

52W Range

10thpctl

Volume

0.01×avg

Mkt Cap

6.67MUSD

P/E

-0.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings